Pharmaceutical Investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
Pharmaceutical Investing Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results
Pharmaceutical Investing Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results
Copper Investing Project Update: Key Progress Milestones at Pumpkin Hollow Undergound Mine and Open Pit Project
Industrial Metals Investing HPQ Silicon Reports 1,900 % Increase In Total Mass Of Silicon Metal Produced By Gen2 PUREVAP Versus Baseline Gen1 Result
Pharmaceutical Investing BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma
Copper Investing Turquoise Hill: Oyu Tolgoi Marks Early Development Milestone with Completion of Shaft 2 Sinking
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
